2021
DOI: 10.1038/s41429-021-00441-2
|View full text |Cite
|
Sign up to set email alerts
|

The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 81 publications
0
11
0
Order By: Relevance
“…Sedaghat (2021) stated that taurine exerts its antiapoptotic effect by inhibiting the mitochondrial pathway and reverting the gene expression of Bax/Bcl-2 to normal, as reported herein. Besides, caspase-3 and caspase-9 were also inhibited by taurine (Madbouly et al 2021).…”
Section: Discussionmentioning
confidence: 94%
“…Sedaghat (2021) stated that taurine exerts its antiapoptotic effect by inhibiting the mitochondrial pathway and reverting the gene expression of Bax/Bcl-2 to normal, as reported herein. Besides, caspase-3 and caspase-9 were also inhibited by taurine (Madbouly et al 2021).…”
Section: Discussionmentioning
confidence: 94%
“…Oxidative Medicine and Cellular Longevity the formation of free radicals, lipid peroxides, and protein adducts that subsequently provoke renal cell damage [3,4,7,9]. Moreover, renal oxidative stress is believed to trigger inflammation by upregulating several proinflammatory cytokines (e.g., IL-1β, IL-6, and TNF-α, HSP25, and TLR4) with simultaneous inhibition of IL-10, which is a robust anti-inflammatory molecule [10][11][12]. Our results agree with many prior studies that advocated major roles for oxidative stress and inflammation in the pathomechanisms of renal injury caused by AK [3,4,7,[9][10][11][12].…”
Section: Discussionmentioning
confidence: 99%
“…The rats were divided after acclimatization to four equal groups, as follows (n = 8 rats/group): normal controls (NC), positive controls (PC) that were injected with amikacin only, and the last groups which concurrently received amikacin with either low (200 mg/kg; LD group) or high (400 mg/kg; HD group) oral BCP (Sigma-Aldrich Chemical Co.; MO, USA) doses. The normal group was injected intraperitoneally with normal saline, whilst freshly prepared intraperitoneal amikacin injections (500 mg/kg; AMIKACIN®; EIPICO Pharmaceuticals Co.; 10 th of Ramadan City, Egypt) alone or together with low or high oral BCP doses were given once daily to the assigned animals for 14 successive days, as described earlier [11,15,22]. Ethical approval was granted by the Ethics Board at Umm Al-Qura University, KSA (AMSEC 17/06-12-21).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations